SEPTODONT NV-SA
ActiveSEPTODONT NV-SA has been active since 1976 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €996k and a net result of €266k. Equity is shrinking by ~27.7% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2028. Its solvency ranks better than 25% of 4860 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
63
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability63▼-13
Solvency48▼-5
Growth38▼-26
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 6.45 against 3.4 in 2024; short-term debt: 13.4% and cash: 0% of total assets), but 77% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
23%
Return on assets
6.1%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-05-2026, 73 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
73 d early
2024
50 d early
2023
69 d early
2022
53 d early
2021
45 d early
2020
12 d early
2019
67 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€8.73M▼ 27.7%
2024 · €12.07M
2019: €6.63M
2020: €6.25M
2021: €7.76M
2022: €8.75M
2023: €11.19M
2024: €12.07M
2019 → 2025
EBIT margin
3.8%▲ 1.7pp
2024 · 2.1%
2019: 4.0%
2020: 5.2%
2021: 5.7%
2022: -28.9%
2023: 2.3%
2024: 2.1%
2019 → 2025
Net result
€266k▼ 99.9%
2024 · €373.16M
2019: €16.83M
2020: €2.12M
2021: €16.49M
2022: €2.71M
2023: €2.50M
2024: €373.16M
2019 → 2025
Working capital
€3.16M▼ 26.1%
2024 · €4.28M
2019: €-414k
2020: €-414k
2021: €-3.97M
2022: €-1.30M
2023: €1.18M
2024: €4.28M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€7.76M-€8.75M▲ 12.7%€11.19M▲ 27.9%€12.07M▲ 7.9%€8.73M▼ 27.7%
Equity€642k-€570k▼ 11.2%€3.07M▲ 439%€1.73M▼ 43.7%€996k▼ 42.4%
Operating result€445k-€-2.52M€259k€252k▼ 2.5%€333k▲ 32.1%
Net result€16.49M-€2.71M▼ 83.5%€2.50M▼ 7.8%€373.16M▲ 14,815%€266k▼ 99.9%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 32% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.33M
Fixed assets
€584k▲ 201%
Current assets
€3.74M▼ 38.3%
Equity and liabilities €4.33M
Equity
€996k▼ 42.4%
Provisions
€2.73M=
Debt
€605k▼ 66.4%
The debt ratio falls from 28.8% to 14.0%. Equity and debt are lower.
Key figures and ratios
EBITDA
€363k▲
2024 · €284k
Cash flow
€296k▼
2024 · €373.19M
Solvency
23.0%▼
2024 · 27.7%
Current ratio
6.45▲
2024 · 3.40
Quick ratio
5.21▲
2024 · 2.62
Debt / equity
0.61▼
2024 · 1.04
ROE
26.7%
ROA
6.1%
Interest coverage
8.44▼
2024 · 17.19
Debt
€605k▼
2024 · €1.80M
Debt ≤ 1 year
€580k▼
2024 · €1.79M
Income taxes
€115k▼
2024 · €377k
Staff costs
€2.59M▲
2024 · €2.56M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€6.26M€4.33M▼
Fixed assets21/28€194k€584k▲
Intangible fixed assets21€3k€400k▲
Tangible fixed assets22/27€191k€184k▼
Land and buildings22€110k€104k▼
Plant, machinery and equipment23€53k€48k▼
Furniture and vehicles24€27k€31k▲
Financial fixed assets28€0€0=
Affiliated companies280/1€0€0=
Participating interests280€0€0=
Current assets29/58€6.06M€3.74M▼
Stocks and contracts in progress3€1.39M€720k▼
Stocks30/36€1.39M€720k▼
Goods purchased for resale34€1.39M€720k▼
Amounts receivable within one year40/41€4.66M€3.02M▼
Trade receivables40€2.41M€1.65M▼
Other amounts receivable41€2.25M€1.37M▼
Cash at bank and in hand54/58-€16
Deferred charges and accrued income490/1€14k€8k▼
Equity and liabilities
Total equity and liabilities10/49€6.26M€4.33M▼
Equity10/15€1.73M€996k▼
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€8k€8k=
Non-distributable reserves130/1€7k€7k=
Legal reserve130€6k€6k=
Other1319€1k€1k=
Tax-exempt reserves132€710€710=
Profit (loss) carried forward14€1.66M€926k▼
Provisions and deferred taxes16€2.73M€2.73M=
Provisions for liabilities and charges160/5€2.73M€2.73M=
Taxes161€2.73M€2.73M=
Amounts payable17/49€1.80M€605k▼
Amounts payable within one year42/48€1.79M€580k▼
Trade debts44€1.33M€65k▼
Suppliers440/4€1.33M€65k▼
Taxes, remuneration and social security45€458k€515k▲
Taxes450/3€38k€74k▲
Remuneration and social security454/9€420k€441k▲
Accrued charges and deferred income492/3€16k€25k▲
Income statement
Code20242025
Operating income70/76A€12.20M€9.40M▼
Turnover70€12.07M€8.73M▼
Other operating income74€126k€672k▲
Operating charges60/66A€11.94M€9.07M▼
Goods for resale, raw materials and consumables60€7.88M€4.99M▼
Purchases600/8€8.28M€4.30M▼
Change in stocks: decrease (increase)609€-405k€694k▲
Services and other goods61€1.45M€1.39M▼
Remuneration, social security and pensions62€2.56M€2.59M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€32k€30k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€11k€-25k▼
Other operating charges640/8€13k€90k▲
Operating profit (loss)9901€252k€333k▲
Financial income75/76B€373.30M€95k▼
Recurring financial income75€1.06M€95k▼
Income from current assets751€1.06M€93k▼
Other financial income752/9€2k€2k▼
Non-recurring financial income76B€372.24M-
Financial charges65/66B€20k€48k▲
Recurring financial charges65€20k€48k▲
Debt charges650€17k€43k▲
Other financial charges652/9€4k€5k▲
Profit (loss) for the period before taxes9903€373.54M€381k▼
Income taxes67/77€377k€115k▼
Taxes670/3€377k€118k▼
Tax adjustments and reversals of tax provisions77-€3k
Profit (loss) for the period9904€373.16M€266k▼
Profit (loss) for the period to be appropriated9905€373.16M€266k▼
Appropriation of the result
Profit (loss) to be appropriated9906€376.16M€926k▼
Profit (loss) brought forward from the previous period14P€3.00M€661k▼
Profit to be distributed694/7€374.50M-
Return on contributions (dividend)694€374.50M-
Social balance
Average headcount (FTE)908715.414.0▼
The notes to these accounts (46 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
19-05
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Weakest financial yearnet €266k ▼99.9%
Net result drops to €266k, the lowest in the series.
11-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Highest result since 2019net €373.16M ▲14815%
Net result €373.16M, the highest in the series.
23-05
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Liquidity triplescurrent ratio 2.22
Current ratio from 0.66 to 2.22; short-term debt falls from €3.80M to €966k.
31-12
Financial
Equity above €2MEq €3.07M ▲439%
5 profitable years in a row build equity to €3.07M.
08-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
16-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
19-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
25-05
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
30-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 61 days late
2018
26-12
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 148 days late
2017
21-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2025
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
25-11-2025
Franck Chaulet: Resigned as Director
25-11-2025
Olivier Schiller: Resigned as Director
19-05-2025
Sandro Calay: Resigned as Daily management
23-06-2023
SEPTODONT HOLDING: Resigned as Director
18-07-2019
Tom Preneel: Resigned as Managing director
01-06-2015
Luc Malachane: Resigned as Director
Location & real-estate footprint
Registered office, Ganshoren · 1 establishment unit since 1976
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Grondwetlaan 871083 GanshorenGround area
365 m²
Building footprint
266 m²
Volume, LiDAR
2,253 m³
Parcel 21392B0026/00V009, Brussels · tallest building 15.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
SEPTODONT NV-SA
since 19762.012.051.105
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21392B0026/00V009 | Brussels | 365 m² | 1 · 266 m² | 15.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ORTHO SINA
BE 0889.872.555
Jette · Eq €999k
REVIMEX
BE 0443.312.566
Pelt · Eq €1.00M
LABORATOIRES FORTE PHARMA BENELUX
BE 0867.510.788
Brussel · Eq €990k
Hillrom Belgium
BE 0821.256.042
Braine-l'Alleud · Eq €990k
DIMED MEDICAL ENGINEERING
BE 0451.042.674
Antwerpen · Eq €1.00M
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 759 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded05-02-1976
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 50 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesWebsite:www.septodont.be
E-mail:info@septodont.be